 3i Infotech Limited allots 3,77,08,165 equity shares on rights basis, Issue oversubscribed 1.45 times
3i Infotech Limited allots 3,77,08,165 equity shares on rights basis, Issue oversubscribed 1.45 times Reliance Power Ltd appoints retired IAS Officer Ms. Zohra Chatterji as Independent Director
Reliance Power Ltd appoints retired IAS Officer Ms. Zohra Chatterji as Independent Director Airfloa Rail Technology Ltd receives order worth Rs. 23.91 crores
Airfloa Rail Technology Ltd receives order worth Rs. 23.91 crores Macfos Ltd consolidated Q2FY26 net profit up QoQ at Rs. 5.10 crore
Macfos Ltd consolidated Q2FY26 net profit up QoQ at Rs. 5.10 crore Jasch Gauging Technologies Ltd Q2 FY2025-26 net profit at Rs. 5.13 crore
Jasch Gauging Technologies Ltd Q2 FY2025-26 net profit at Rs. 5.13 crore 
              The Union Cabinet today gave its approval to the establishment of National Institute of Biomedical Genomics ( (NIBMG) at Kalyani in Nadia District of West Bengal as an autonomous institution under the aegis of Department of Biotechnology, Ministry of Science & Technology with the budgetary provision of rs.210 crores. The institute will be a society registered under the Societies Registration Act, and will be governed by the Governing Body.
The Institute has emphasis towards enhancement of knowledge on human health & disease through genomics and translate the knowledge using appropriate technologies for promotion of well being and improvement of genomics-based health-care in India.
NIBMG will create necessary physical infrastructure and build capacity to serve as the expert base for the establishment of principles and practice of biomedical genomics and promote cutting-edge research in biomedical genomics for better understanding and reduction of public-health burden in India. The grand vision is to provide personalised, predictive, preventive and therapeutic healthcare through the use of genomic knowledge.
NIBMG will usher in the genomics era explicitly in the areas of medicine and public-health. It will undertake novel research, translational, educational & training programmes, network with relevant institutions through star alliance, and seed biomedical genomics activities in hospitals, medical school and other health-care institutions.